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Abstract: Metabolomic profiling of biofluids, e.g., urine, plasma, has generated vast and ever-
increasing amounts of knowledge over the last few decades. Paradoxically, metabolomic analysis 
of saliva, the most readily-available human biofluid, has lagged. This review explores the history of 
saliva-based metabolomics and summarizes current knowledge of salivary metabolomics. Current 
applications of salivary metabolomics have largely focused on diagnostic biomarker discovery and 
the diagnostic value of the current literature base is explored. There is also a small, albeit promising, 
literature base concerning the use of salivary metabolomics in monitoring athletic performance. 
Functional roles of salivary metabolites remain largely unexplored. Areas of emerging knowledge 
include the role of oral host–microbiome interactions in shaping the salivary metabolite profile and 
the potential roles of salivary metabolites in oral physiology, e.g., in taste perception. Discussion of 
future research directions describes the need to begin acquiring a greater knowledge of the function 
of salivary metabolites, a current research direction in the field of the gut metabolome. The role of 
saliva as an easily obtainable, information-rich fluid that could complement other gastrointestinal 
fluids in the exploration of the gut metabolome is emphasized. 
Keywords: whole-mouth saliva; parotid saliva; gingival–crevicular fluid; submandibular/ 
sublingual fluid; oral microbiome; metabolic profiling; NMR; MS  
 
1. Introduction 
Saliva is a biological fluid produced in the oral cavity by three pairs of major glands and up to 
one thousand minor glands. It is important to make the distinction between the different fluids that 
may be described under the umbrella term “saliva”. When referring to the fluid produced upon 
spitting or drooling, whole-mouth saliva (WMS) would be a more apt descriptor. This reflects the fact 
that WMS is essentially the net product of major and minor glands, eukaryotic cells (epithelial and 
leukocytic), bacteria, and gingival–crevicular fluid (GCF) [1]. GCF is a serum-derived filtrate that 
enters the mouth at the gingival margins of the teeth. While the non-glandular contributions to WMS 
compose only a fraction of the net fluid volume, their contributions to the net composition are 
significant. When referring to saliva produced by specific glands, descriptors are used to denote the 
gland of origin. Fluid produced by the parotid glands is termed parotid saliva (PS), and fluid 
produced by the submandibular gland and sublingual gland is typically described together as 
submandibular/sublingual (SM/SL) saliva. This is due to the fact that the submandibular and 
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sublingual ducts share an opening to the oral cavity, making collection of either fluid in isolation 
extremely impractical, if not impossible. Secretions from minor glands are typically referred to as 
minor gland saliva, although anatomical descriptors are sometimes applied to differentiate the site 
(e.g., labial or palatal) [2]. Contributions to WMS from these various sources are depicted in Figure 1. 
 
Figure 1. A summary of the net contributions to whole-mouth saliva. 
Salivary composition is complex and variable, both between individuals and temporally within 
the same individual [3,4]. Salivary protein composition, both of major salivary proteins and low 
abundance proteins detectable by mass-spectroscopy (MS) proteomics has been comprehensively 
described elsewhere [5–7]. The focus of this review is the metabolite composition of saliva. While 
some studies have included ions under the umbrella of metabolites [8], this review does not make 
such an inclusion and focuses on biologically-derived molecules. Until relatively recently, the 
metabolite composition of saliva has been largely overlooked, or treated as a side-note with respect 
to protein composition. This discrepancy is illustrated in Figure 2, which shows the research outputs 
for salivary proteomics and salivary metabolomics, with the current number of metabolomic studies 
approximating that of proteomic studies one decade ago. Despite this, recent years show a relatively 
high growth of salivary metabolomic research. 
 
Figure 2. A comparison of research outputs for salivary proteomic and metabolomic studies. Data 
was gathered by searching Scopus for the terms “saliva” OR “salivary” AND “proteome” OR 
“proteomics” compared to “saliva” OR “salivary” AND “metabolome” OR “metabolomics” in article 
title fields. 
Historically, the study of salivary metabolites has been confined to a select few analytes, often 
considered in isolation. While this has revealed important knowledge about these metabolites, such 
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as the role of urea in maintenance of salivary pH or lactate in the aetiology of dental caries, systematic 
metabolite profiling of saliva is a relatively recent avenue of research. Saliva offers many advantages 
compared to other biofluids. It can be collected safely and non-invasively with minimal training, it is 
typically produced continually on demand, and it is rich in biological information [9,10]. There are 
several approaches to obtaining saliva, including the use of proprietary products, e.g., Salivette kits, 
which are chewable cotton swabs which absorb saliva. Chewing and taste stimulation are both 
common approaches to increase salivary flow rates, although in practice many studies elect to collect 
saliva passively, by spitting or drooling into a container as the fluid is produced in the mouth. This 
may be referred to in literature as unstimulated whole-mouth saliva (UWMS) [2]. The collection of 
saliva from specific glands can be more complicated. Parotid gland saliva is most commonly collected 
with the use of a Lashley cup, while submandibular and sublingual gland saliva are typically 
collected together by pipetting methods and minor gland saliva can be collected using filter papers 
or capillary tubes [11]. Despite advantages such as ease of collection and preparation, saliva is 
considerably less studied by metabolic profiling compared to fluids such as urine and plasma, as 
evidenced by the number of research outputs on the respective fluids [12]. It is unclear why this is 
the case; however, it could be that a perceived lack of an established literature base would deter 
researchers unfamiliar with salivary collection. Metabolite profiling of fluids such as urine and 
plasma were reported by gas chromatography-MS in the mid 1970s [13], and by proton nuclear 
magnetic resonance spectroscopy (1H-NMR) early 1980s [14,15]. Preliminary metabolic study of 
saliva by 1H-NMR was not published until the late 1980s/early 1990’s by which point, study of plasma 
and urines were established in pathophysiological investigations [16], e.g., of hepatotoxins [17]. The 
early 1H-NMR studies of salivary metabolite composition were performed at low magnetic field 
strengths by modern standards, leading to relatively low resolution. Additionally, minimal 
assignments were made to the spectral peaks, partly due to overlapped resonances from 
macromolecules and insufficient attenuation of the relatively large water resonance [18–20]. The 
earliest 1H-NMR study of saliva with comprehensive assignments was that of Silwood et al., 2003 
[21]. Subsequent studies, although growing, remain low in number relative to those of other biofluids, 
and merit discussion in the following section of this review. With respect to MS-based studies, while 
there is a history of applying the technology to saliva for the targeted detection of analytes such as 
exogenous drugs and their metabolites, comprehensive profiling of saliva by MS emerged in the early 
2010s [22,23].  
2. Approaches to the Study of Salivary Metabolites 
Terminology relating to the study of metabolites can be misused, and there are important 
distinctions between “metabolomics” and “metabonomics”. This review uses the definitions of 
Nicholson (2006) [24]. Metabolomics is thus defined as “the comprehensive quantitative analysis of 
all the metabolites of an organism or specified biological sample”, whereas metabonomics is defined 
as “the quantitative measurement of the multiparametric time-related metabolic responses of a 
complex (multicellular) system to a pathophysiological intervention or genetic modification”. The 
key distinction is that the dynamic nature of biological systems in response to stimuli must be 
considered under metabonomic study. Much of the literature pertaining to saliva would therefore be 
classified as metabolomics, although a number of studies have begun to address salivary metabolic 
changes following stimuli such as taste and mastication. The term “metabolic profiling” is also used 
as a general descriptor for the simultaneous measurement of multiple metabolites in a biological 
sample.  
There are currently two main technologies used in metabolic profiling—NMR and MS. Both 
platforms can be further classified. Protons (1H) are the most common NMR-active nuclei studied in 
salivary metabolomics NMR spectroscopy, although other nuclei such as 13C are also analyzed in 
heteronuclear two-dimensional studies. Such an approach is particularly useful in confirming or 
aiding the assignment of spectral peaks not yet confirmed. As saliva is a liquid, solution state NMR 
is routinely used, however, solid state NMR has successfully been used to characterize metabolites 
in salivary calculi [25]. NMR spectroscopy of WMS can be applied with minimal or no sample pre-
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treatment, although there are advantages to simple steps such as centrifugation to remove cellular 
constituents. MS analysis of saliva typically involves a metabolite extraction process and a separation 
step. With respect to saliva, the commonest approach is liquid chromatography MS (LC-MS), 
although capillary electrophoresis (CE-MS), and gas chromatography-MS (GC-MS) are also used. CE-
MS studies are growing in metabolomics research, and this is true for the study of saliva, with the 
advantages of enhancing the range of polar metabolites detected [26]. MS techniques that do not 
require a separation step e.g. MALDI (matrix-assisted laser desorption ionization) MS are widely 
used in salivary proteomics and while such approaches offer promise in metabolomics of other 
substances, this is not yet common in saliva [27]. Several reviews have been written about the relative 
advantages and limitations of different MS and NMR platforms in metabolomics [28–33]. The 
combination of platforms to maximize data from metabolomic study has been recognized [32]. This 
remains rare in salivary metabolomics to date, although a few studies have taken such an approach 
[8,34].  
To facilitate metabolomic research of biofluids, protocol papers have been published with the 
aim of ensuring validity and allowing comparisons between different studies, addressing issues of 
sample collection, storage, preparation, and analysis. For NMR-based metabolomics, protocols for 
the analysis of urine and plasma are well established and widely used [35,36]. Consequently, results 
from subsequent studies conforming to these standardized protocols can be more readily compared. 
Similar published protocols exist for MS-based metabolomics of these fluids [37,38]. 
Recommendations for saliva preparation for metabolomic analysis by LC-MS, and more recently, by 
1H-NMR have been published [12,22]. A lack of protocol homogeneity is a major complication in the 
meta-analyses of research on salivary metabolomics.  
3. Current Knowledge of the Salivary Metabolome 
There are currently approximately 72 original research articles applying metabolomics to human 
saliva. These can be broadly classified into different types of study as described in Figure 3. Based on 
the definitions in the previous section, preliminary studies into salivary metabolites would largely 
be classified as metabolomic, in that the emphasis was on characterizing and identifying the 
metabolites that can be measured. Nevertheless, studies looking at the dynamic nature of salivary 
metabolites have been published and these are increasing in number. This is particularly true as the 
baseline metabolite composition of saliva in healthy individuals is now fairly well characterized, with 
the majority of NMR spectral assignments “solved” [8], although there remains debate about certain 
peak assignments. As seen in Figure 3, most studies of salivary metabolic composition have focused 
on salivary metabolite profiling as a means of biomarker discovery. Of these studies, eleven have 
looked at oral cancer, eight periodontal disease and six Alzheimer’s disease. The remainder of 
conditions studied are limited to one or two studies at present. Oral cancer has the most extensive 
history of study by salivary metabolomics, as novel diagnostic approaches are sought due to the 
clinical benefit of early detection [39]. It could therefore be argued that these studies are metabonomic 
as they introduce the element of analysis in pathological conditions. A list of studies using salivary 
metabolomics as a source of biomarkers for different oral and systemic diseases is presented in Table 
1.  
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Figure 3. An illustration of the classification of existing original research studies of salivary 
metabolomics. 
As indicated in Table 1, the potential for salivary metabolites as diagnostic biomarkers is 
promising. Many of the studies are self-described pilot or proof of concept studies, featuring 
relatively low numbers of participants, although participant number does vary with the highest 
number of cases being 660 Alzheimer’s disease patients and a comparable number of controls. 
However, implementation of such technologies into clinical diagnostics undoubtedly faces 
challenges at present. For example, the specificity of metabolites such as valine, alanine, lactate, 
propionate, and butyrate as disease indicators is questionable. Metabolites such as valine have been 
found to be upregulated in very different conditions including periodontal disease [40,41] and oral 
cancer [23,42]. Indeed, Sugimoto et al., (2010) [23] found salivary valine was also increased in breast 
and prostate cancer, not just oral cancer. Similarly, propionate has been found to be upregulated in a 
number of diverse pathologies including Alzheimer’s disease [43], dementia [44], periodontal disease 
[40], and dental caries [45]. Therefore, such molecules may be representative of a non-specific 
pathological shift in the salivary metabolome. Furthermore, some studies have reported conflicting 
results. For example, butyrate has been found to be increase or decrease in concentration in 
association with the presence of dental caries [45,46]. It is likely that single metabolites in isolation 
may not yield sufficient diagnostic specificity for most disease, however multivariate analyses may 
offer improved accuracy.  
Further challenges that arise from the current literature base on salivary metabolomics are due 
to heterogeneity between studies. While the studies listed in Table 1 follow a broadly similar 
approach in that they attempt to find differences between diseased individuals and healthy controls, 
there is considerable variation in the, sample collection and preparation methods, analytical 
platforms used, and statistical methods employed. This has been identified in a recent review of 
salivary metabolomics for the diagnosis of oral cancer and periodontal disease, where the degree of 
heterogeneity between studies meant comparison of results from different groups studying the same 
disease was not possible [47]. For biomarkers to become clinically accepted as diagnostically useful, 
systemic reviews of large multi-centre trials must be performed. There is therefore a need for both a 
consensus on sample handling as well as cross-validation of analytical equipment between different 
centres working on such projects. This is typified by the studies of Wang et al., (2014) published 
contemporaneously using the same subject groups and analytical techniques, yet recommending 
different panels of metabolites to discriminate oral cancer from controls [48,49].  
The studies listed in Table 1, particularly those looking at oral malignancy typically look at 
discriminating disease from healthy controls. A major challenge in the diagnosis of oral cancer is in 
determining malignancy from pre-malignant or non-malignant pathology that can have very similar 
clinical presentations to cancer. Metabonomic studies comparing such conditions remain scarce, 
although multivariate analysis of data from HPLC/MS analysis of saliva has been shown to 
discriminate oral squamous cell carcinoma from oral lichen planus and oral leukoplakia, although 
peak identification was not confirmed [50]. A more recent study also found salivary metabolomics 
could separate lichen planus from oral cancer, finding discriminatory metabolites upregulated in oral 
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cancer included indoleacetate, putrescine and phosphoethanolamine [51]. Oral cancer and 
precancerous dysplasia have also been separated from other clinically similar lesions including 
keratosis and inflammation [52].  
Further study of similar oral diseases by metabolomics may aid in clarifying pathogenesis and 
disease classification. For example, recently there have been international changes in the classification 
of periodontal disease, with aggressive and chronic periodontitis no longer considered separate 
diseases [53]. Metabolomic evidence supports such a decision from a functional perspective as it was 
found that there was no metabolomic difference between individuals with aggressive and chronic 
periodontitis [41]. Salivary metabolomics has also been applied to the study of prognostic biomarkers 
in periodontal disease following surgical therapy. A shift in the metabolomic profiles of saliva was 
observed following treatment, indicative of a return from the disease state to a healthy state [54]. 
Since treatment outcomes from periodontal disease can be difficult to predict the enhanced 
understanding of the underlying pathology offered by metabolomics is invaluable.  
Ultimately, more work is needed for the translation of salivary metabolomics into useful 
diagnostic aids. This will be facilitated by the adoption of standardized analytical protocols. The 
technical aspects of sample preparation and analysis are only one aspect of such protocols. Wider 
aspects of salivary physiology that might impact on metabolite profile, including timing of collection, 
choice of stimulus, and participant behaviors must also be considered and steps taken by researchers 
to standardize these considerations. Prior to characterizing changes in salivary metabolome brought 
about by disease, it is important to thoroughly characterize the temporal changes in salivary 
metabolome that occur in health. Work has been conducted to this end, identifying important 
considerations.  
Table 1. A summary of studies investigating the potential of salivary metabolomics in biomarker 
discovery. 
Disease 
(n. Disease vs. n. 
Control) 
Metabolomic 
Technique 
Biomarkers Identified  
(Raised/Lowered in Disease) 
Reference 
Oral Cancer 
69 v. 87) 
 
 
 
(24 v. 44) 
 
 
 
(37 v. 34) 
 
 
 
 
 
(30 v. 30) 
 
 
 
 
 
(101 v. 35) 
 
 
(22 v. 18) 
 
 
 
 
 
 
Capillary electrophoresis 
time-of-flight mass 
spectrometry (CE-TOF-
MS) 
 
 CE-TOF-MS 
 
 
 
Ultraperformance liquid 
chromatography coupled 
with quadrupole-
TOFMS (UPLC-
QTOFMS) 
 
Reverse phase liquid 
chromatography and 
hydrophilic interaction 
chromatography with 
TOF-MS 
 
1H-NMR and LC-
MS/MS 
 
UPLC-QTOFMS 
 
 
 
 
 
 
Alanine, taurine, leucine/isoleucine, histidine, valine, 
tryptophan, glutamate, threonine, carnitine, pipecolic acid  
 
 
3-phosphoglycerate, carnosine, phosphoenolpyruvate, 
dihydroxyacetonephosphate  
Pipecolate, s-adenosylmethionine 
 
 
Lactate, n-Eicosanoic acid 
Valine, γ-aminobutyric acid (GABA), Phenylalanine 
 
 
 
 
Propionylcholine, succinic acid, lactic acid  
Acetylphenylalanine, carnitine, phytosphingosine 
 
 
 
Glycine, proline 
 
 
 
1-methylhistidine, inositol 1,3,4-triphosphate, dglycerate-2-
phosphate, 4-nitroquinoline-1-oxide, 2-oxoarginine, 
norcocaine nitroxide, sphinganine-1-phosphate, 
pseudouridine 
L-homocysteic acid, ubiquinone, neuraminic acid, estradiol 
valerate 
 
 [23] 
 
 
 
 
 [55] 
 
 
 
 
 [42] 
 
 
 
 
 [48] 
 
 
 
 
 [34] 
 
 
 
 [56] 
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(22 v. 18) 
 
 
 
 
 
 
 
 
 
(7 v. 7) 
 
 
 
Oral Leukoplakia 
(32 v. 34) 
 
 
Breast Cancer 
(30 v. 87) 
 
(124 v. 42) 
 
Prostate Cancer 
(18 v. 87) 
 
Periodontal Disease 
(11 v. 87) 
 
 
(21 v. 22) 
 
 
 
(n = 909, 
significant 
correlations 
between 
[metabolite] and 
disease severity) 
 
(50 v. 50) 
 
 
 
 
(62 v. 52) 
 
 
(30 v. 15) 
 
 
(26 v. 25) 
 
 
Periodontal Disease 
(Aggressive) 
(28 v. 39) 
 
Periodontal Disease 
(Chronic) 
(33 v. 39) 
 
Dental Caries 
(15 v. 18) 
 
CE-MS 
 
 
 
 
 
 
 
 
 
LC-MS/MS, LC-MS, 
GC-MS 
 
 
 
UPLC-QTOFMS 
 
 
CE-TOF-MS 
 
 
CE- and LC-MS 
 
CE-TOF-MS 
 
 
 
CE-TOF-MS 
 
 
Proton nuclear magnetic 
resonance spectroscopy 
(1H-NMR) 
 
Ultra-high performance 
liquid chromatography 
and tandem MS 
(UHPLC-MS/MS)  
 
 
 
GC-MS and LC-MS 
 
 
 
 
1H-NMR 
 
 
1H-NMR 
 
 
1H-NMR 
 
 
 
 
1H-NMR 
 
 
1H-NMR 
 
 
1H-NMR 
 
 
Choline, hydroxyphenylacetic acid, 2-hydroxy-4-
methylvaleric acid, valine, 3-phenyllactic acid, leucine, 
hexanoic acid, octanoic acid, terephthalic acid, γ-
butyrobetaine, 3-(4-hydroxyphenyl)propionic acid, 
isoleucine, tryptophan, 3-phenylpropionic acid, butyric 
acid, cadaverine, 2-oxoisovaleric acid, trimethyllysine, 
taurine, glycolic acid, 3-hydroxybutyric acid, heptanoic 
acid, alanine 
Urea 
 
Guanosine-3-monophosphate, N-acetylputrescine, 2-
Hydroxyglutarate, Adenosine-3-monophosphate, Uracil, 
Spermidine, 3-Glycosyl tryptophan 
 
 
Isoleucine, phenylalanine, threonine, homocysteine, n-
tetradecanoic acid, 4-methoxyphenylacetic acid  
 
Alanine, leucine/isoleucine, valine, glutamate  
Taurine, Threonine 
 
Polyamines, spermine 
 
Alanine, leucine/isoleucine, histidine, valine, tryptophan, 
glutamic acid, threonine, carnitine 
Taurine 
 
Alanine, leucine/isoleucine, valine, tryptophan, threonine 
Pipecolic acid, taurine  
 
Acetate, GABA, propionate, n-butyrate, succinate, 
trimethylamine, valine 
Pyruvate, n-acetyl groups 
 
Phenylpropionate, phenylacetate  
 
 
 
 
 
 
Hydroxyeicosatetraenoic acid, prostaglandins, isoprostanes, 
thromboxane 
Hydroxyoctadecadienoic acid, prostacylcin 
 
 
Alanine, valine, leucine, glutamate, succinate, lactate 
Pyruvate 
 
Methanol, acetone 
Taurine, lactate 
 
Butyrate 
GABA, lactate, methanol, threonine 
 
 
 
Isoleucine, proline, valine, tyrosine, phenylalanine  
Lactate, pyruvate, n-acetyl groups  
 
Formate, phenylalanine, tyrosine  
Sarcosine, Lactate, pyruvate, n-acetyl groups 
 
Propionate, butyrate 
Saccharides 
 
 [57] 
 
 
 
 
 
 
 
 
 
[58] 
 
 
 
 
 [42] 
 
 
 [23] 
 
 
 [59] 
 
 [23] 
 
 
 
 [23] 
 
 
 [40] 
 
 
 
 [60] 
 
 
 
 
 
 
[61] 
 
 
 
 
 [62] 
 
 
 [63] 
 
 
[64] 
 
 
 
 
 [41] 
 
 
 [41] 
 
 
 [45] 
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(15 v. 23) 
 
 
Primary Sjögren’s 
Syndrome 
(12 v. 21) 
 
(15 v. 15) 
 
Dementia 
(10 v. 9) 
 
(17 v. 34) 
 
 
Alzheimer’s Disease 
(256 v. 218) 
 
 
 
(32 v. 45) 
 
 
(9 v. 12) 
 
(25 v. 25) 
 
 
 
Alzheimer’s Disease 
(relative to mild 
cognitive 
impairment;  
(660 v. 586) 
 
Mild cognitive 
impairment relative 
to health 
(20 v. 20) 
 
Parkinson’s disease 
(76 v. 37) 
 
 
Celiac disease 
(13 v. 13) 
 
 
Sarcoidosis 
(24 v. 45) 
 
Recurrent aphthous 
ulceration 
(45v. 49) 
 
Untreated HIV 
(21 v. 8) 
 
Treated HIV 
(Antiretroviral 
therapy) 
(12 v. 8) 
 
Hepatitis B 
(20 v. 16) 
 
1H-NMR 
 
 
 
Gas chromatography-
MS (GC-MS) 
 
1H-NMR 
 
 
CE-TOF-MS 
 
1H-NMR 
 
 
Faster ultra-
performance liquid 
chromatography-MS 
(FUPLC-MS) 
 
LC-MS 
 
 
1H-NMR 
 
Flow injection analysis- 
tandem mass spec. (DFI-
MS/MS) 
 
(FUPLC-MS) 
 
 
 
 
 
 
LC-MS 
 
 
 
1H-NMR 
 
 
 
 
GC-MS 
 
 
 
1H-NMR 
 
 
LC-MS/MS 
 
 
 
1H-NMR 
 
 
 
1H-NMR 
 
 
 
1H-NMR 
 
Extensive list of amino acids and organic acids 
Butyrate, acetone 
 
 
39 metabolites including organic acids, amino acids and 
carbohydrates 
 
Alanine, glycine, butyrate, taurine, phenylalanine, choline, 
tyrosine  
 
Tyrosine, arginine 
 
Acetate, histamine, propionate  
Dimethyl sulfone, glycerol, succinate, taurine  
 
Sphinganine-1-phosphate, ornithine, phenyllactic acid 
Inosine, 3-dehydrocarnitine, hypoxanthine 
 
 
 
Histidinyl-Phenylalanine, methylguanosine, choline-
cytidine 
 
Acetone, propionate 
 
acyl-alkyl phosphatidylcholines 
 
 
 
Sphinganine-1-phosphate, cytidine, pyroglutamic acid, L-
glutamic acid, L-tryptophan, ornithine, phenyllactic acid 
3-dehydrocarnitine, hypoxanthine, Inosine  
 
 
 
 
Taurine, several putative di- and tripeptides 
 
 
 
Histidine, tyrosine, phenylalanine, acetate, n-acetyl groups, 
propionate, Isoleucine, lysine, glycine, valine, GABA, 
fucose, trimethylamine, trimethylamine-oxide, alanine, 
acetoin 
 
Carbon disulfide, 1-chlorodecane, trichloromethane 
Alcohols, phenols, ketones 
 
 
Lactate, acetate 
Methanol, n-acetyl groups 
 
Tryptophan, 5-methoxytryptamine, 5-methoxytryptophan 
Estrone sulfate, 17β-Estradiol 3-sulfate, 
Dehydroepiandrosterone sulfate 
 
Butyrate, Lactate 
 
 
 
Butyrate, Lactate, propionate 
 
 
Propionate, acetate, succinate, putrescine, tyrosine 
Lactate, pyruvate, butyrate, 4-hydroxybenzoate, 4-
pyridoxoate 
 [46] 
 
 
 
 [65] 
 
  
 [66] 
 
 
 [67] 
 
 [44] 
 
 
 [68] 
 
 
 
 
 [69] 
 
 
[43] 
 
[70] 
 
 
 
[71] 
 
 
 
 
 
 
[72] 
 
 
 
[73] 
 
 
 
 
 [74] 
 
 
 
 [75] 
 
 
 [76] 
 
 
 
[77] 
 
 
 
[77] 
 
 
 
[78] 
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Medication- related 
osteonecrosis of the 
jaw 
(17 v. 18) 
 
Parotid gland 
tumour 
(36 v. 23) 
 
 
Obesity 
(22 v. 46) 
 
Paediatric obesity 
(18 v. 23) 
 
External apical root 
resorption in 
orthodontic therapy 
(8 v. 11) 
 
 
 
 
CE-MS 
 
 
 
1H-NMR 
 
 
HPLC-MS/MS and GC-
MS 
 
GC-MS 
 
 
 
 
1H-NMR 
 
 
 
 
Hypotaurine 
 
 
 
Alanine, threonine, leucine, serine, valine 
Formate, succinate 
 
Creatinine, phosphate, cadaverine, dipeptides, putrescine 
 
 
Palmitic acid, myristic acid, urea, N-acetyl galactosamine 
 
 
 
 
Butyrate, urea, glucose, formate, fumarate 
 
 
 
[79] 
 
 
 
[80] 
 
 
[81] 
 
 
[82] 
 
 
 
 
[83] 
An important consideration for salivary composition is the timing of sample collection, as 
salivary composition including total protein is known to display circadian rhythms [84]. MS 
metabolic profiling showed the majority (85%) of salivary metabolites do not have an apparent 
circadian pattern, however the remaining 15% of salivary metabolites exhibit circadian effects [85]. 
The majority of these circadian-regulated metabolites are amino acids, with tyrosine and arginine, 
for example, appearing to mirror the circadian pattern of total protein concentration. Circadian effects 
gave also been demonstrated by NMR metabolic profiling [86]. The NMR salivary metabolite profile 
has also been shown to vary more within a day than between days, although the flow rate of saliva 
was demonstrated to be independent from the metabolic variations [87]. Nevertheless, the intra-
individual variation of salivary metabolite profile both within a day and between days has been 
shown to be considerably lower than inter-individual variation [88], indicating salivary metabolites 
can discriminate between individuals. Importantly, the first saliva collected on waking was found to 
be significantly richer in many metabolites which may represent changes in saliva production during 
sleep [88]. Salivary metabolic content has also been found to be independent of diet, as dietary 
standardization can reduce inter-individual variation in the metabolic composition of urine, but a 
similar reduction was not observed with saliva [89].  
The metabolic composition of saliva is also influenced by stimulation and certain participant 
behaviors. Stimulation using citric acid caused a decrease in the majority of metabolites measured 
[90,91]. While this decrease is largely attributable to dilution due to increased fluid content of the 
saliva, metabolites were not diluted proportionally, indicating metabolite specific effects [91]. 
Stimulation by chewing also appears to cause contrasting changes in metabolite concentration 
compared to citric acid stimulation. Whereas citric acid stimulation reduced the concentration of 
metabolites, chewing has been demonstrated in both MS and 1H-NMR studies to cause an increase in 
the concentration of the majority of metabolites. This was attributed to the mechanical action of 
chewing liberating metabolites from oral biofilms [92,93]. A large MS study of physiological and 
environmental factors demonstrated salivary metabolite profile is not significantly affected by 
lifestyle factors such as alcohol consumption, fasting, oral hygiene, medication use or nutritional 
supplementation. The largest effects were observed for sex, followed by collection method and then 
smoking. Body mass index (BMI) was shown to have an effect only when comparing underweight 
individuals to healthy weight, but not when comparing overweight individuals. Menstrual status 
had no effect when considering female participants [94]. 1H-NMR analyses have found salivary 
metabolite profile is independent of sex and BMI when considering net metabolite profile [86], 
although sex-based metabolic differences have been found when quantifying individual metabolites 
[91]. Collection method is another caveat for the metabolomic study of saliva, with the use of 
collection systems as opposed to passive drooling being identified as a potential source of exogenous 
analytes in samples [46].  
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4. Role of Host–Microbiome Interactions in Modifying Salivary Metabolic Composition 
The role of oral microbial communities in shaping the salivary metabolome has been speculated 
in literature, and the need for further research into this area has been identified. Only recently is the 
true extent of microbial contributions to WMS metabolite composition becoming appreciated. This 
was demonstrated by comparison of sterile parotid gland saliva with WMS, which reveals that prior 
to entering the oral cavity, glandular saliva is devoid of many WMS metabolites such as acetate, 
butyrate and propionate, collectively known as short-chain fatty acids (SCFAs). Furthermore, the 
concentration of many WMS metabolites including SCFAs, amines, phenylalanine, glycine, and 
succinate correlate strongly with the bacterial load in WMS [95]. Such a finding has significant 
implications for the diagnostic utility of these metabolites, as highlighted in the previous section, as 
certain metabolites that have been identified as putative biomarkers may be reflective of changes in 
the oral microbiome. These may not reflect a specific disease process but, for example, a general 
impairment of oral hygiene for various reasons, i.e., pain or discomfort in oral cancer and periodontal 
disease or reduced physical and mental ability to care for oneself in cognitive diseases. Host-derived 
salivary metabolites include lactate, citrate, and urea. Urea has been shown to negatively correlate 
with salivary bacterial load as well as dental plaque as it is utilized by oral bacteria [60,95]. Previous 
metabolomic study of PS has been complicated by low spectral resolution or low number of donors 
[20,96]. 1H-NMR spectra of SM/SL saliva have also been published but these suffer from the same low 
resolution as well as the presence of sialadenitis (gland inflammation) in the donor [20]. Figure 4 
shows a comparison between PS and SM/SL saliva collected from the same donor. The spectra are 
highly similar indicating that there are no major differences in metabolite composition of saliva 
collected from the different major glands. Another major salivary metabolite of host origin is taurine. 
Taurine is an abundant metabolite in many animal tissues [97], although its entrance into saliva has 
remained unclear, particularly as salivary levels exceed circulating plasma levels despite taurine 
being absent from glandular saliva. Taurine is present at high concentrations in GCF and is likely 
concentrated via immune cells which have been shown to be capable of concentrating up to 50 mM 
taurine [98].  
 
Figure 4. Partial 600 MHz 1D 1H-NMR spectra (δ0.7 to 8.5 ppm, excluding δ4.5 to 5.5 ppm), comparing 
a. submandibular/sublingual saliva and b. parotid saliva from the same donor. Prominent peaks are 
labelled. Samples were collected and spectra were acquired on separate occasions as previously 
described [95]. Spectra are scaled to the lactate peak to assess relative metabolite concentrations. The 
acetate in a. reflects some cross-contamination with WMS during collection as 
submandibular/sublingual saliva was pipetted from the floor of the mouth upon secretion, inevitably 
contacting the oral cavity briefly. 
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As well as contributing heavily to the net metabolic composition of WMS at rest, the oral 
microbiomes will also rapidly alter salivary metabolite composition upon exposure to fermentable 
carbohydrates. This process has been known for eight decades and was proved by the use of 
traditional biochemical methods [99]. More recently, metabolomics has been used to visualize this 
process in dental plaque [100,101]. The changes seen in plaque following exposure to glucose are also 
mirrored in saliva following exposure to sucrose. Although 1H-NMR metabolomics does not have 
the sensitivity to detect certain glycolysis pathway intermediates, salivary metabolites such as lactate, 
pyruvate, succinate, acetoin, and alanine have been observed to increase after exposure to sucrose 
[12]. There is also preliminary evidence for the intra-oral breakdown of other exogenous substances 
including non-nutritive sweeteners. Following oral exposure to aspartame, salivary aspartate and 
phenylalanine concentrations (the constituent amino acids of aspartame) increased. Whether this is 
due to host or microbial peptidases is not clear [90]. 
A further area lacking in knowledge at present is the substrate for oral microbes. For example, 
acetate, which is the most concentrated salivary metabolite has been previously speculated as 
resulting from degradation of either dietary carbohydrates [8] or collagen and amino acid catabolism 
in the absence of carbohydrate sources [40]. One of the major differences between the gut and oral 
microbiomes, and their respective metabolomes is the availability of exogenous nutrients. In the oral 
cavity this is transient in most individuals, and saliva clears carbohydrates from the oral cavity by its 
physical and enzymatic actions typically within an hour [102,103]. In the colon however, undigested 
fermentable nutrient sources are a more constant presence. Nevertheless, salivary metabolites are 
generated in the absence of exogenous carbohydrate as evidence by the fact that salivary metabolites 
on waking are generally more concentrated than at other times throughout the day [88]. As salivary 
flow rate was not reported by Wallner-Liebmann et al. (2016) [88], some of this concentration increase 
may simply be due to a reduced salivary flow on waking compared to other times of the day [84]. 
The metabolite concentration increases were not uniform, however, suggesting genuine changes in 
metabolite production. The largest fold changes in metabolite concentration on waking relative to 
later in the day were 15.7, 6.0, 3.6, 3.5, and 3.1 for valine, trimethylamine, butyrate, methylamine, and 
choline, respectively. Large increases in free valine are suggestive of proteolysis, and butyrate 
production may represent the terminal metabolite in a range of amino-acid catabolic pathways, 
particularly lysine [104,105]. Methylamine and trimethylamine are products of microbial choline 
metabolism [106], and choline itself may be increased due to reduced salivary clearance of shed 
buccal epithelial cells during sleep [12]. It is appreciated that salivary proteins are a source of 
nutrients for oral bacteria although this is also recognized as an area of limited study [107]. Recently 
it has been shown that oral microbial biofilms will catabolize salivary proteins, generating abundant 
SCFAs, proline, 5-aminopentanoate, and putrescine. Consumption of succinate and lactate from the 
baseline sterilized saliva was also observed [108].  
5. Potential Physiological Significance of Salivary Metabolites 
To date, the physiological significance of salivary metabolites is largely unknown. Unlike in the 
colon, where bacterial generated metabolites such as SCFAs, lactate and succinate are known to have 
important roles in host health, equivalent function for these same metabolites in the oral cavity are 
unknown. SCFAs are known to have an important role in maintaining epithelial integrity in the gut. 
This is particularly true for butyrate, which upregulates tight junction expression and regulates 
proliferation of colonic epithelial cell, via histone deacetylase inhibition, upregulating expression of 
genes promoting apoptosis [109,110]. Gut SCFAs have also been demonstrated to have immune 
regulation functions, metabolic functions, and to play a role in regulation of host satiety and appetite 
[109,111,112]. These functions are typically mediated by the actions of SCFAs on G-protein coupled 
receptors (GPCRs) [111,113]. Additional microbial-derived metabolites in the gut have been shown 
to exert physiological functions via their role as signaling molecules [111]. These include succinate 
and lactate, both of which are present in saliva. Succinate is traditionally considered a citric-acid cycle 
intermediate although recently evidence is emerging to support its role as regulator of 
gluconeogenesis as well as having anti-inflammatory effects [114]. Lactate has similarly been long 
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considered a metabolic waste product, although evidence for diverse physiological functions is 
emerging including immune regulation, anti-inflammatory properties and maintenance of epithelial 
barriers [115]. Enabling cross-feeding between different microbial species is a further important 
function of metabolites such as succinate and lactate [116].  
Given the growing appreciation of the interaction between gut metabolites and host behaviors 
such as taste and nutrient detection [112], modulation of taste receptors by microbial products has 
been proposed [117]. Such a hypothesis has not yet been directly investigated in humans, although 
associations between salivary metabolomics and sensory perception have been investigated. The 
most convincing evidence to date is concerning the sensory perception of oleic acid. It has been 
demonstrated that, compared to sensitive oleic acid perceivers, insensitive oleic acid perceivers have 
higher concentrations of salivary acetate and butyrate and lower concentrations of lysine and fatty 
acids [118]. Furthermore, differences in salivary metabolite composition following oral exposure to 
oleic acid were observed between sensitive and insensitive oleic acid perceivers. Sensitive perceivers 
were characterized by increases in acetate, propionate, formate, lysine, valine and GABA, whereas 
insensitive perceivers were characterized by increases in galactose, glucose, lactate, threonine, 
phosphocholine, and ethanolamine [119]. This evidence cannot be used to infer a causal relationship 
between salivary metabolites and sensory perception. Given the strong evidence linking many of 
these metabolites to oral microbial activity, however, these studies do present a solid evidence base 
to support the hypothesis that oral microbial activity is related to host oral nutrient sensing. There is 
additional evidence of an association between other salivary metabolites and sensory perception. 
These include an inverse association between salivary glucose and sweet sensitivity [120], although 
this was only found in female participants, and a similar relationship between salivary urea and bitter 
taste sensitivity in renal disease participants [121]. While glucose tastes sweet and urea tastes bitter, 
it is unlikely salivary levels would approach the concentrations necessary to be perceptible and 
directly mask exogenous tastants [122,123]. Both molecules, however, do represent endogenous 
salivary nutrients that will be consumed by oral bacteria to different extents, so may serve as useful 
markers of net oral microbial function.  
Another interesting area of salivary metabolomics that is emerging is in sports and exercise 
physiology. Saliva represents an ideal fluid in the monitoring of athletic performance, where repeated 
sampling of blood may be excessively invasive or even detrimental to performance. Traditionally one 
of the best studied salivary analytes in this regards is lactate, often assayed in isolation. Plasma lactate 
is widely used in sports medicine as an indicator of performance and training intensity, as it is 
accumulates during anaerobic respiration when the rate of lactate production exceeds the rate of 
removal [124]. Salivary lactate levels have been shown to closely correlate with plasma levels 
following exercise in both short- and long-distance runners [125,126]. Furthermore, exercise-induced 
increases in salivary lactate are reproducible and independent of post-exercise reduction in salivary 
flow rate [125]. Recently, salivary metabolomics is identifying new metabolic markers of exercise 
tolerance and sports performance. Metabolites indicative of skeletal muscle use and muscle 
catabolism such as 3-methylhistidine and taurine have been putatively identified [127], with the latter 
being found to correlate with distance travelled by soccer players [128]. Several other salivary 
metabolites have been found to reflect performance following standardized bouts of exercise. These 
include metabolites associated with increased energy demands such as creatine, inositol, glucose, 
citrate and lactate [129]. Other metabolites of less obvious functions in man such as δ-valerolactam 
(2-piperidone) have also been implicated in changing post-exercise [130]. It was speculated that δ-
valerolactam could be a product of cadaverine metabolism, a known lysine degradation product in 
saliva. Recently recommendations were made to address challenges of using salivary metabolomics 
in association with exercise. A major challenge is in accounting for coinciding changes in fluid volume 
brought about by exercise. Approaches to account for this effect included normalizing metabolite 
concentration to either salivary total protein or osmolality. Both approaches were believed to have 
merit, with neither being definitively recommended. An important recommendation was regarding 
timing of sample collection, which should be without delay upon cessation of exercise [131].  
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Little is known about how salivary SCFAs interact with oral epithelial cells. It has been shown 
that in TR146 cells (a squamous cell carcinoma derived cell line commonly used to model buccal 
epithelium), acetate and lactate have an inhibitory effect on cell growth. This was only observed at 
relatively high concentrations, 20–30 mM acetate, and 10–20 mM lactate [132]. These concentrations 
are an order of magnitude higher than those typically found in saliva. Propionate and butyrate have 
been studied in association with gingival fibroblasts. Butyrate conferred a dose-dependent inhibitory 
effect on gingival fibroblasts at concentrations of 2–4 mM. Propionate also inhibited gingival 
fibroblasts at concentrations of 4–8m mM, however, growth inhibition was not seen for all donor 
samples, suggesting a less generalized inhibitory effect than that of butyrate [133]. It is possible that 
in cases of severe periodontal disease, butyrate and propionate concentrations would exceed these 
minimum in-vitro inhibitory concentrations [134]. Taurine has also been studied in association with 
periodontal disease. Epithelia from excised gingival tissue have been shown to grow more efficiently 
on collagen membranes hydrated with 1% taurine than on control collagen membranes [135]. 
Furthermore, daily oral administration of 500 mg taurine has been shown to improve both circulating 
and local redox status (within gingival pockets) as well as improve clinical indicators of periodontal 
disease within fifteen days [136].  
Recent evidence has implicated salivary citrate in association with the physical properties of 
saliva [137]. Whether there is a causative role for citrate in contributing to the extensional rheology 
of saliva is at present unclear, as is any precise mechanism. Other salivary analytes associated with 
salivary rheology include calcium and bicarbonate [138], and it is known that calcium chelation is an 
important step for the unpacking of salivary glycoproteins (viscoelastic macromolecules) following 
secretion [139,140]. It is possible that the interactions between calcium, citrate, bicarbonate, and 
glycoproteins at the point of salivary secretion ultimately determine the net physical properties of 
the resulting fluid. Alternatively, salivary citrate may simply be a product of gland stimulation 
alongside other constituents such as mucin but is not otherwise involved in mediating the physical 
properties.  
6. Future Directions for Salivary Metabolomics 
Omics technologies can be thought of as providing stratified degrees of biological information. 
Genomic analysis summarizes the potential genetic information present in a biological system. 
Transcriptomics and proteomics can then reveal the translation of this biological information into 
biomolecules with functional potential. However, only metabolomics will provide information on 
the net function of transcribed, translated and modified proteins within the biological system being 
studied [141,142]. Gene sequencing technologies previously revolutionized oral microbiology, 
greatly enhancing the information gained about the microbial species occupying the oral cavity, up 
to half of which are unculturable [143]. In a similar fashion, metabolomic analysis may represent the 
next paradigm shift in oral microbiology, with the functional information gained about these complex 
microbial communities being identified as a key area of future study [104]. This concept has been 
demonstrated as valid and useful in the study of how the gut metabolome reflects the gut microbiome 
[144]. 
At present, very few studies have studied saliva using both sequencing and metabolomics 
technologies. The most comprehensive study of this type has made steps in elucidating the 
relationships between salivary metabolites and associated microbial species [145]. There is a clear 
need for future work to reconcile the functional information provided by metabolomics with the oral 
microbial composition and host factors that may modify the latter. Therefore, further studies with a 
combined analytical approach will be essential in future. Another aspect of salivary metabolomics 
that will merit further study is concerning the dynamic nature of the metabolic events that occur in 
the mouth. Currently, the majority of studies analyze a single sample from each participant which 
essentiality creates a static “snapshot” of the present biochemical activity. While some studies have 
analyzed multiple samples from participants, usually with the aim of characterizing the temporal 
stability and reproducibility of salivary metabolite profiles, sampling intervals are typically of the 
order of hours [87,88]. Preliminary studies have shown that significant metabolic changes occur in 
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the order of seconds when the oral environment is exposed to changes brought about by activities 
such as nutrient intake or oral hygiene. This has been demonstrated both in-vitro with several single 
species biofilms [100], and in-vivo [101]. A combination of in-vitro and in-vivo work is a useful 
approach to breaking down the complexity of the oral metabolome, as controlled environments can 
be created in-vitro, allowing investigation of events that would otherwise be obscured in-vivo.  
A final consideration for future metabolomic studies is the cross-disciplinary study of multiple 
biofluids. This is particularly prudent in regard to saliva, given one of the main advantages of 
studying saliva is the ease of collection. Much of the knowledge of the human microbiome, microbial 
metabolome and resulting consequences for host health stems from study of the gut, with equivalent 
oral study remaining minimal, (Figure 5). The oral cavity and gut represent portions of the same 
biological system, and there would almost certainly be great benefit in enhancing how the metabolic 
activity of these microbial communities relates to each other. For example, if it could be demonstrated 
that certain disease-related dysbiotic changes in the gut are reflected in oral cavity then this finding 
would simplify diagnosis in the future.  
 
Figure 5. A comparison of the cumulative publications for metabolomics and microbiome studies of 
the gut and oral cavity. Data was collected from Scopus by searching publications with “gut 
metabolome”, ”gut microbiome”, ”oral OR saliva metabolome”, and ” oral OR saliva microbiome” in 
the title field. Note that the total publications for microbiome studies are considerably greater than 
metabolome studies for both the gut and oral cavity. 
7. Conclusions 
Salivary metabolomics is gaining recognition as a valuable source of biological information. Of 
particular importance is the fact that much of the metabolite content of saliva is derived from the oral 
microbiome. Although the majority of metabolites that are detectable in saliva by 1H-NMR have been 
identified, there remains considerable work in interpreting the significance of these different 
metabolites. It is anticipated that future work concerning the salivary metabolome will focus on 
determining whether salivary metabolites possess functional roles and deepening the understanding 
of the relationship between metabolome and microbial function. Researchers working on 
metabolomics of other biofluids should be encouraged to consider whether the complementary use 
of saliva could augment their work. This is pertinent as saliva is easy to collect and the collection, 
handling and preparation of saliva for metabolomic analysis has been fairly well researched and is 
relatively simple.  
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